|
|
|
Volumn 42, Issue 1089, 2000, Pages 94-95
|
|
Zonisamide (Zonegran) for epilepsy
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM CHANNEL;
CARBAMAZEPINE;
CARBONATE DEHYDRATASE INHIBITOR;
DOPAMINE;
KETOCONAZOLE;
PHENOBARBITAL;
PHENYTOIN;
SEROTONIN;
SODIUM CHANNEL;
TOPIRAMATE;
ZONISAMIDE;
ABDOMINAL PAIN;
ADULT;
ATAXIA;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOPAMINERGIC TRANSMISSION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG POTENTIATION;
EPILEPSY;
FOCAL EPILEPSY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MAJOR CLINICAL STUDY;
NAUSEA;
RANDOMIZED CONTROLLED TRIAL;
SEROTONINERGIC SYSTEM;
SHORT SURVEY;
SOMNOLENCE;
TONIC CLONIC SEIZURE;
VERTIGO;
ADULT;
ANTICONVULSANTS;
ATAXIA;
BIOLOGICAL AVAILABILITY;
CALCIUM CHANNEL BLOCKERS;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
EPILEPSY;
HALF-LIFE;
HUMANS;
ISOXAZOLES;
|
|
EID: 0034596912
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|